Guía de Práctica Clínica sobre Cuidados Paliativos - Cedepap TV

211. Assessment, Evaluation, and Management of Suicidal Patients. Disponible en http://www.cancer.gov/cancertopics/pdq/supportivecare/depression/HealthProfessional/page5. PDQ®Cancer Information Summaries: Supportive Care. Depression (PDQ®). National CancerInstitute.; 2007.212. De Conno F, Sbanotto A, Ripamonti C, Ventafrida V. Mouth care. In: Doyle D, Hanks G,Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford:Oxford University Press; 2004. p. 1117-33.213. Worthington H, Clarkson J, Eden O. Interventions for preventing oral mucositis for patientswith cancer receiving treatment. Cochrane Database of Systematic Reviews. 2007;2.214. Clarkson J, Worthington H, Eden O. Interventions for treating oral mucositis for patientswith cancer receiving treatment. Cochrane Database of Systematic Reviews. 2007;2, 2007.215. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, et al. Updatedclinical practice guidelines for the prevention and treatment of mucositis. Cancer.2007;109(5):820-31.216. Barasch A, Elad S, Altman A, Damato K, Epstein J. Antimicrobials, mucosal coating agents,anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. SupportCare Cancer. 2006;14(6):528-32.217. Peterson DE, Jones JB, Petit RG. Randomized, placebo-controlled trial of Saforis for preventionand treatment of oral mucositis in breast cancer patients receiving anthracycline-basedchemotherapy. Cancer. 2007;109(2):322-31.218. Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, et al. Palifermin reduces theincidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-basedchemotherapy. J Clin Oncol. 2006;24(33):5194-200.219. Oneschuk D, Hanson J, Bruera E, Oneschuk D, Hanson J, Bruera E. A survey of mouth painand dryness in patients with advanced cancer.[see comment]. Supportive Care in Cancer.2000;8(5):372-6.220. Dirix P, Nuyts S, Vander Poorten V, Delaere P, Van den Bogaert W. The influence of xerostomiaafter rediotherapy on quality of life: results of a Support Care Cancer. 2008;16(2):171-9.221. Symptomatic Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer Patients.Practice Guideline Report # 5-5. Head & Neck Cancer Evidence-based Series and PracticeGuidelines 2004http://www.cancercare.on.ca/pdf/full5_1.pdf [Acceso Junio 2007]222. Davies A, Shorthose K. Parasympathomimetic drugs for the treatment of salivary gland dysfunctiondue to radiotherapy. Cochrane Database Syst Rev. 2007;(3):CD003782.223. von B, I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, et al. Salivary dysfunctionassociated with systemic diseases: systematic review and clinical management recommendations.[Review] [163 refs]. Oral Surgery Oral Medicine Oral Pathology Oral Radiology &Endodontics. 2007;103 Suppl:S57-15.224. Watson MS, Lucas C.F, Hoy AM, Back IN. Gastrointestinal symptoms. Oxford Handbookof Palliative Care.New York: Oxford University press; 2005. p. 237-82.225. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines fortreatment of candidiasis. Clin Infect Dis. 2004;38(2):161-89.226. Pankhurst CL. Candidiasis (oropharyngeal). Clin Evid. 2006;(15):1849-63.GUÍA DE PRÁCTICA CLÍNICA SOBRE CUIDADOS PALIATIVOS 299